Halfmann, Peter J. http://orcid.org/0000-0002-1648-1625
Loeffler, Kathryn http://orcid.org/0009-0005-4935-5819
Duffy, Augustine http://orcid.org/0009-0007-4984-4633
Kuroda, Makoto
Yang, Jie E. http://orcid.org/0000-0002-2438-8156
Wright, Elizabeth R. http://orcid.org/0000-0003-0712-9475
Kawaoka, Yoshihiro http://orcid.org/0000-0001-5061-8296
Kane, Ravi S. http://orcid.org/0000-0003-3084-4098
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (P01AI165077, P01AI165077)
Article History
Received: 20 June 2023
Accepted: 25 January 2024
First Online: 12 February 2024
Competing interests
: The authors declare the following competing interests: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. The other authors declare no competing interests.